Pharmaceutical Analysis & Statistics in Japan, September 2014 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: therapeutics, drug, cancer, more »

61-110 of about 1 100 reports

Purchase Reports From Reputable Market Research Publishers

Key Pharma News 15 SEPTEMBER 2014

Key Pharma News 15 SEPTEMBER 2014

  • $ 1 415
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Merck Beats BMS To Market With Anti-PD-1 Therapy Industry Trend Analysis - Calico Collaboration To Further Expand AbbVie's Portfolio Industry Brief - Chugai Amends Business Arrangements ...

  • Industries : Pathology
  • Countries : Japan, United States
Asia-Pacific Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

Asia-Pacific Anticoccidial Drugs Market - Global Trends And Forecasts - (2014-19)

  • $ 1 250
  • Industry report
  • August 2014
  • by Mordor Intelligence LLP

The Asia Pacific market is the fastest growing market for anticoccidials. This is primarily due to the increased demand for meat protiens in countries like China, India, Malaysia etc. The increased demand ...

  • Industries : Drug and Medication
  • Countries : China, World, India, Asia, Australia, Malaysia, Japan
 Japanese Encephalitis-Pipeline Insights, 2014

Japanese Encephalitis-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Japanese Encephalitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug Discovery and Development
  • Countries : Japan
Japan Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Japan Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Japan’s pharmaceutical industry is a compulsory destination for manufacturers of patented drugs and, increasingly, generic and over-the-counter (OTC) medicines. The regulatory regime has many ...

  • Industries : Drug and Medication
  • Countries : Japan
Anti-Infective Drug News 06 OCTOBER 2014

Anti-Infective Drug News 06 OCTOBER 2014

  • $ 1 114
  • Industry report
  • October 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Gilead Acts To Secure Its Reign Over HIV-1 Market Industry Brief - Vibativ Now Available In Europe For HAP/VAP Industry Brief - FDA Grants Fast Track Designation For MEDI3902 ...

  • Industries : Drug and Medication
  • Countries : Japan, Canada
CNS Drug News 15 SEPTEMBER 2014

CNS Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - FDA-Approved Contrave Enters Tough And Competitive Market Industry Trend Analysis - Nuplazid's FDA Breakthrough Therapy Designation Boosts ACADIA Industry Brief - Phase IIa Study ...

  • Industries : Drug and Medication
  • Countries : United States, Canada, Japan
Cancer Drug News 15 SEPTEMBER 2014

Cancer Drug News 15 SEPTEMBER 2014

  • $ 1 114
  • Industry report
  • September 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - Boom In Antibody-Drug Conjugate Market On The Horizon Industry Brief - First Patient Dosed In Phase II Study Of Lucitanib In Advanced BC Industry Trend Analysis - SGX301 Has Potential ...

  • Industries : Drug and Medication
  • Countries : Canada, Japan, United States, Sweden, China, World
Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)

Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)

  • $ 800
  • Industry report
  • September 2014
  • by Daedal Research

Scope of the Report The report titled “Global Glaucoma Treatment Market: Trends and Opportunities (2014-2019)” provides an insight into the glaucoma treatment market over the years with a special focus ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2014 Update

Brainsway Ltd. (BRIN) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Brainsway Ltd. (Brainsway) is a manufacturer of medical devices. The company develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of a wide ...

  • Industries : Pathology
  • Countries : United States, Japan
Hisamitsu Pharmaceutical Co., Inc. (4530) - Product Pipeline Analysis, 2014 Update

Hisamitsu Pharmaceutical Co., Inc. (4530) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Hisamitsu Pharmaceutical Co., Inc. (Hisamitsu Pharmaceutical) is a pharmaceutical company. The company manufactures and sells pharmaceuticals and related products to the healthcare industry. It ...

  • Industries : Drug Delivery Technology
  • Countries : Philippines, Japan, Singapore
Medikit Co., Ltd. (7749) - Product Pipeline Analysis, 2014 Update

Medikit Co., Ltd. (7749) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary Medikit Co., Ltd. (Medikit) is a medical device company. The company manufactures and sells vascular access medical devices. Its products include Supercath Z3V, Supercath 5 safety IV catheter, ...

  • Industries : Drug Discovery and Development
  • Countries : Vietnam, Japan
MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

MicroVention, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary MicroVention, Inc. (MicroVention) is a medical device company. The company develops catheter based technologies for the endovascular treatment of peripheral and cerebral vascular diseases. Its ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Costa Rica, North America, Canada, France, Germany, Japan
STAAR Surgical Company (STAA) - Product Pipeline Analysis, 2014 Update

STAAR Surgical Company (STAA) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary STAAR Surgical Company (STAAR) is a medical device company. The company designs, develops, manufactures and markets implantable lenses for the eye and delivery systems. Its products include refractive ...

  • Industries : Drug Delivery Technology
  • Countries : United States, Japan
NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis, 2014 Update

NeuroMetrix, Inc. (NURO) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • September 2014
  • by Global Data

Summary NeuroMetrix, Inc. (NeuroMetrix) is a medical device company. The company develops wearable medical technology and point-of-care diagnostics. It offers products such as SENSUS, DPNCheck and ADVANCE ...

  • Industries : Pathology
  • Countries : United States, Japan
Abacavir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Abacavir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Acitretin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Acitretin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Adefovir  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Adefovir - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Armodafinil  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Armodafinil - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Atovaquone  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Atovaquone - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Caspofungin  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Caspofungin - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Celecoxib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Celecoxib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Duloxetine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Duloxetine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Pathology
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Dutasteride  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Dutasteride - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Drug and Medication
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
Imatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Imatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States
Lasofoxifene  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Lasofoxifene - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • October 2014
  • by Ark Patent Intelligence

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension ...

  • Industries : Generic Drug
  • Countries : United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World
About 800 reports

Download Unlimited Documents from Trusted Public Sources

Ono Pharmaceutical Company - Company Report, October 2014

  • Ono Pharmaceutical Co., Ltd.
  • October 2014
  • Pharmaceutical  

  • Japan  

View report >

14 Companies

Read our Company Profiles

Icon Group

United States

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.